Pete Savage lab research, UChicago

Advanced Imaging

Program Leaders: Greg Karczmar, PhD, and Aytekin Oto, MD

The University of Chicago Medicine Comprehensive Cancer Center is at the forefront of the developing innovative imaging technologies and analysis approaches that is transforming cancer care. Extraordinary advances in imaging pioneered by investigators in the Advanced Imaging Program are leading to the ability diagnose cancer in its early, less harmful stages and attack tumors with greater precision and with less harm to healthy tissue. Imaging is also a crucial element in cancer treatment, as it can be used to assess response to therapy and better deliver cancer therapy, thereby improving effectiveness and reducing off-target effects in normal tissue. Research in the Advanced Imaging Program, consisting of 22 members spanning a wide variety of disciplines, ranges from preclinical studies in cells and animal models of cancer, to clinical trials.

The key research themes of the Advance Imaging Program include:

  • Develop novel imaging-based approaches for cancer risk assessment and early detection;
  • Improve understanding of cancer biology using imaging, thereby enabling the development of new non-invasive, image-based tumor biomarkers;
  • Optimize imaging technologies and approaches for improved treatment response assessment and image-guided therapy; and
  • Develop new technology for image acquisition and novel data analysis and bioinformatics tools.
  • Current Members

    Hiroyuki Abe, MD
    Hania Al-Hallaq, PhD
    Daniel Appelbaum, MD
    Samuel Armato, PhD
    Issam Awad, MD
    Bulent Aydogan, PhD
    Kenneth Bader, PhD
    Chin-Tu Chen, PhD
    Abraham Dachman, MD
    Maryellen Giger, PhD
    Howard Halpern, MD, PhD
    Yasmin Hasan, MD
    Yulei Jiang, PhD
    Chien-Min Kao, PhD
    Gregory Karczmar, PhD
    Patrick La Riviere, PhD
    Stanley Liauw, MD
    Heber MacMahon, MB, BCh
    Aytekin Oto, MD
    Xiaochun Pan, PhD
    Yonglin Pu, MD, PhD
    Steffen Sammet, MD, PhD